Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 25(17): 3706-10, 2015 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-26112445
2.
Bioorg Med Chem Lett ; 25(12): 2514-8, 2015 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-25971769

RESUMEN

A series of bicyclic pyrazole carboxamides was synthesized and tested for inhibitory activity against the class III deacetylase sirtuin enzymes. Moderate to low micromolar inhibitory activities were obtained against SIRT1 and SIRT2. These bicyclic pyrazole compounds represent a new class of sirtuin inhibitors with a preference for SIRT1 over SIRT2.


Asunto(s)
Compuestos Bicíclicos con Puentes/química , Pirazoles/química , Sirtuina 1/antagonistas & inhibidores , Sirtuina 2/antagonistas & inhibidores , Sitios de Unión , Dominio Catalítico , Cristalografía por Rayos X , Evaluación Preclínica de Medicamentos , Simulación de Dinámica Molecular , Unión Proteica , Pirazoles/síntesis química , Pirazoles/metabolismo , Sirtuina 1/metabolismo , Sirtuina 2/metabolismo , Relación Estructura-Actividad
3.
J Chem Inf Model ; 54(11): 3198-210, 2014 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-25280064

RESUMEN

The use of predictive computational methods in the drug discovery process is in a state of continual growth. Over the last two decades, an increasingly large number of docking tools have been developed to identify hits or optimize lead molecules through in-silico screening of chemical libraries to proteins. In recent years, the focus has been on implementing protein flexibility and water molecules. Our efforts led to the development of Fitted first reported in 2007 and further developed since then. In this study, we wished to evaluate the impact of protein flexibility and occurrence of water molecules on the accuracy of the Fitted docking program to discriminate active compounds from inactive compounds in virtual screening (VS) campaigns. For this purpose, a total of 171 proteins cocrystallized with small molecules representing 40 unique enzymes and receptors as well as sets of known ligands and decoys were selected from the Protein Data Bank (PDB) and the Directory of Useful Decoys (DUD), respectively. This study revealed that implementing displaceable crystallographic or computationally placed particle water molecules and protein flexibility can improve the enrichment in active compounds. In addition, an informed decision based on library diversity or research objectives (hit discovery vs lead optimization) on which implementation to use may lead to significant improvements.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Simulación del Acoplamiento Molecular , Proteínas/química , Proteínas/metabolismo , Solventes/química , Agua/química , Ligandos , Conformación Molecular , Conformación Proteica , Interfaz Usuario-Computador
4.
J Med Chem ; 55(14): 6306-15, 2012 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-22765237

RESUMEN

Our docking program, Fitted, implemented in our computational platform, Forecaster, has been modified to carry out automated virtual screening of covalent inhibitors. With this modified version of the program, virtual screening and further docking-based optimization of a selected hit led to the identification of potential covalent reversible inhibitors of prolyl oligopeptidase activity. After visual inspection, a virtual hit molecule together with four analogues were selected for synthesis and made in one-five chemical steps. Biological evaluations on recombinant POP and FAPα enzymes, cell extracts, and living cells demonstrated high potency and selectivity for POP over FAPα and DPPIV. Three compounds even exhibited high nanomolar inhibitory activities in intact living human cells and acceptable metabolic stability. This small set of molecules also demonstrated that covalent binding and/or geometrical constraints to the ligand/protein complex may lead to an increase in bioactivity.


Asunto(s)
Inhibidores de Proteasas/farmacología , Serina Endopeptidasas/metabolismo , Interfaz Usuario-Computador , Animales , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Humanos , Microsomas Hepáticos/metabolismo , Modelos Moleculares , Prolil Oligopeptidasas , Inhibidores de Proteasas/síntesis química , Inhibidores de Proteasas/química , Inhibidores de Proteasas/metabolismo , Conformación Proteica , Ratas , Serina Endopeptidasas/química , Relación Estructura-Actividad , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA